Layla Haddad

Built quantitative models at a hedge fund, then got more interested in explaining them than running them. Covers markets and data.

Articles by Layla Haddad

Latest Posts

Crypto

Crypto.com Earns Top AI Certification in Industry Boom

Crypto.com Secures ISO/IEC 42001 AI Certification During Rapid Expansion Crypto.com has marked a significant milestone by becoming the pioneering digital

Read

Crypto

Michael Terpin Predicts Bitcoin Drop to $43,500

Bitcoin may have already erased half of its market cap, but veteran crypto investor Michael Terpin says the asset still has further to fall before hitting rock bottom. In his recent discussion, Terpin emphasizes that the market has not yet reached the true low point and that additional declines are

Read

Markets

Japanese Stocks Surge After Takaichi’s Snap Election Victory

Japanese stock markets have experienced a notable upswing following Sanae Takaichi’s overwhelming triumph in the recent snap election. This political

Read

Personal Finance

Using Junior ISAs for Smart Inheritance Tax Strategies

Junior ISAs, often abbreviated as JISAs, are gaining popularity as a powerful instrument for inheritance planning, particularly with the upcoming

Read

Personal Finance

Ensuring Fairness in Car Finance Agreements

Vehicles provide unparalleled freedom and mobility compared to any other mode of transportation, yet owning a car also brings ongoing

Read

Crypto

Gemini Space Station Stock Plunges 13% on Tuesday

Preliminary Results and Executive Exits Trigger Sell-Off Tuesday marked a challenging day for Gemini Space Station (NASDAQ: GEMI), the cryptocurrency

Read

Economy

ING: ‘Sell America’ Trade Causes Lasting Harm to US Dollar

The United States economy expanded at an annualized pace of 4.4% during the most recent year for which gross domestic

Read

Investing

Netflix Buy Opportunity: Warner Bros. Deal Boosts Growth

Netflix’s Dominant Position in Global Streaming Netflix stands as the preeminent force in the worldwide streaming industry, boasting a subscriber

Read

Investing

Vertex Pharmaceuticals: Resilient Biotech for Any Market Downturn

Vertex Pharmaceuticals possesses the financial strength and revenue potential to thrive regardless of prevailing market conditions. Although Vertex Pharmaceuticals (NASDAQ:

Read